|
|
Article: Biogen Idec Authorizes $3B Stock Buy-Back.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
After authorizing a $20 million share repurchase last October, Biogen Idec Inc.'s board of directors approved a second stock buy-back plan, this time for a whopping $3 billion.
Biogen Idec certainly has the money for such a deal. The Cambridge, Mass.-based company reported about $2.5 billion in cash, equivalents and securities as of March 31 and generated $716 million in first quarter revenues. Yet the repurchase will be funded half through cash and half through debt, ensuring that Biogen Idec remains capable of pursuing "small to moderate-sized acquisitions," according to Jose Juves, director of public affairs.
Earlier this year, ...
Related newspaper, magazine, and journal articles:
|
|
Article: BIOGEN IDEC CUTTING STAFF TO REDUCE COSTS, TIGHTEN ...
BIOWORLD Today;
September 12, 2005 ;
700+ words
... ... issues. (See BioWorld Today, June 20, 2005.) Biogen Idec also is seeking ... of strength." Biogen Idec reported net income ... effort to position Biogen Idec for the years 2010 ... Juves told BioWorld Today. "It will provide ...
|
|